0001179110-16-022870.txt : 20160406 0001179110-16-022870.hdr.sgml : 20160406 20160406182338 ACCESSION NUMBER: 0001179110-16-022870 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160404 FILED AS OF DATE: 20160406 DATE AS OF CHANGE: 20160406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 1180 VETERANS BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Maynard Ryan D CENTRAL INDEX KEY: 0001363984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 161558498 MAIL ADDRESS: STREET 1: RIGEL PHARMACEUTICALS, INC. STREET 2: 1180 VETERANS BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2016-04-04 0 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001363984 Maynard Ryan D RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP & CFO Employee Stock Option (right to buy) 3.59 2016-04-04 4 A 0 62500 0 A 2024-02-27 Common Stock 62500 62500 D Employee Stock Option (right to buy) 2.14 2016-04-04 4 A 0 175000 0 A 2025-01-26 Common Stock 175000 175000 D On February 27, 2014, the reporting person was granted an option to purchase 62,500 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. On January 26, 2015, the reporting person was granted an option to purchase 175,000 shares of common stock. The option vests based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 4, 2016, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. /s/ Dolly Vance (Attorney-in-Fact) 2016-04-06